Polatuzumab Vedotin (Polivy)

polatuzumab vedotin · Genentech (Roche)

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Polatuzumab Vedotin (Polivy), covering 2025-01-29 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma [Phase 2]